13 | Chalcone (Benzalacetophenone)IBA
02/2022
-
04/2005 |
9 | flavokawain AIBA
02/2022
-
04/2005 |
6 | Proteins (Proteins, Gene)FDA Link
01/2021
-
03/2010 |
6 | flavokawain BIBA
01/2019
-
10/2010 |
4 | Pharmaceutical PreparationsIBA
01/2019
-
02/2011 |
4 | Phosphotransferases (Kinase)IBA
03/2017
-
01/2004 |
4 | AgarIBA
08/2012
-
04/2005 |
3 | SurvivinIBA
02/2022
-
04/2005 |
3 | Docetaxel (Taxotere)FDA Link
11/2021
-
02/2011 |
3 | Lysine (L-Lysine)FDA Link
01/2021
-
06/2013 |
3 | RNA (Ribonucleic Acid)IBA
01/2021
-
04/2014 |
3 | S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA
10/2020
-
12/2015 |
3 | Androgen Receptors (Androgen Receptor)IBA
01/2018
-
10/2010 |
3 | AndrogensIBA
01/2017
-
11/2005 |
3 | DiterpenesIBA
12/2016
-
07/2013 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
12/2016
-
07/2013 |
3 | CateninsIBA
08/2016
-
08/2012 |
3 | Insulin-Like Growth Factor I (IGF-1)IBA
01/2014
-
01/2004 |
2 | LycopeneIBA
11/2021
-
02/2011 |
2 | Histones (Histone)IBA
01/2021
-
06/2013 |
2 | 1,3,5,8- tetrahydroxy- 2,4- bis(3- methyl- 2- butenyl)xanthoneIBA
01/2020
-
01/2013 |
2 | xanthoneIBA
01/2020
-
01/2013 |
2 | EnzymesIBA
01/2020
-
06/2013 |
2 | LigandsIBA
01/2019
-
08/2011 |
2 | Biological ProductsIBA
01/2018
-
11/2005 |
2 | rhodiolosideIBA
12/2017
-
03/2012 |
2 | Trastuzumab (Herceptin)FDA Link
03/2017
-
01/2004 |
2 | Kaurane DiterpenesIBA
12/2016
-
07/2013 |
2 | Conditioned Culture MediaIBA
08/2016
-
05/2008 |
2 | Metformin (Glucophage)FDA LinkGeneric
03/2016
-
12/2015 |
2 | Retinoblastoma ProteinIBA
12/2015
-
12/2013 |
2 | Messenger RNA (mRNA)IBA
04/2015
-
03/2010 |
2 | Small Interfering RNA (siRNA)IBA
04/2015
-
05/2008 |
2 | jaridoninIBA
01/2015
-
07/2013 |
2 | Hormones (Hormone)IBA
04/2014
-
10/2010 |
2 | Biomarkers (Surrogate Marker)IBA
06/2013
-
08/2012 |
2 | Cadherins (E-Cadherin)IBA
06/2010
-
07/2007 |
1 | F-Box ProteinsIBA
01/2021 |
1 | Monoamine Oxidase (MAO)IBA
01/2021 |
1 | Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2021 |
1 | AmidesIBA
04/2020 |
1 | Growth InhibitorsIBA
01/2020 |
1 | Proteasome InhibitorsIBA
01/2019 |
1 | Gabapentin (Neurontin)FDA LinkGeneric
01/2019 |
1 | Death Domain ReceptorsIBA
01/2019 |
1 | Bortezomib (Velcade)FDA Link
01/2019 |
1 | benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
01/2019 |
1 | Proto-Oncogene Proteins c-mdm2IBA
01/2018 |
1 | 25-methoxydammarane-3,12,20-triolIBA
01/2018 |
1 | GinsenosidesIBA
01/2018 |
1 | yangoninIBA
09/2017 |
1 | Caspase 9IBA
01/2017 |
1 | oridoninIBA
12/2016 |
1 | Acetylcysteine (Siran)FDA LinkGeneric
12/2016 |
1 | Hypoglycemic Agents (Hypoglycemics)IBA
03/2016 |
1 | Adenosine Monophosphate (AMP)IBA
03/2016 |
1 | physapubescinIBA
01/2016 |
1 | ResveratrolIBA
12/2015 |
1 | AerosolsIBA
10/2015 |
1 | Neuropilin-2IBA
04/2015 |
1 | Cysteine (L-Cysteine)FDA Link
01/2014 |
1 | BenzaldehydesIBA
01/2014 |
1 | Transforming Growth Factor beta (TGF-beta)IBA
01/2014 |
1 | Insulin-Like PeptidesIBA
01/2014 |
1 | Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2014 |
1 | ChalconesIBA
01/2014 |
1 | AcetophenonesIBA
01/2014 |
1 | 3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA
11/2013 |
1 | TriazolesIBA
11/2013 |
1 | MethyltransferasesIBA
06/2013 |
1 | CarcinogensIBA
06/2013 |
1 | Telomerase (Telomerase Reverse Transcriptase)IBA
06/2013 |